Heart Rhythm
Volume 2, Issue 12 , Pages 1294-1300, December 2005

Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases

  • Kathryn A. Phillips, PhD

      Affiliations

    • School of Pharmacy, Institute for Health Policy Studies, and UCSF Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Kathryn A. Phillips, School of Pharmacy, Institute for Health Policy Studies, and UCSF Comprehensive Cancer Center, University of California, San Francisco, 3333 California Street #420, Box 0613, San Francisco, California 94143.
    • ,
  • Michael J. Ackerman, MD, PhD

      Affiliations

    • Departments of Medicine, Pediatrics, and Molecular Pharmacology, Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Julie Sakowski, PhD

      Affiliations

    • Sutter Health Institute for Research and Education, San Francisco, California
    • Dr. Sakowski was located at the University of California, San Francisco, when much of this research was completed.
    • ,
  • Charles I. Berul, MD

      Affiliations

    • Department of Cardiology, Children’s Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts

Received 22 March 2005; accepted 26 August 2005. published online 03 September 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Partial funding was provided by Genaissance Pharmaceuticals, Inc., through independent consulting contracts to Dr. Phillips and Dr. Ackerman. All results and conclusions are those of the authors and should not be construed to represent those of Genaissance Pharmaceuticals.

PII: S1547-5271(05)02018-7

doi:10.1016/j.hrthm.2005.08.026

Heart Rhythm
Volume 2, Issue 12 , Pages 1294-1300, December 2005

Article Tools

* Image Usage & Resolution